Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01789268 · ClinicalTrials.gov registry record
Impact of Respiratory Pathogens in Infants
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 267
- Enrollment target
NCT01789268: Completed study, sponsored by University of Rochester.
NCT01789268 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 267 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01789268 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 267 participants
- Enrollment target
Study Summary
This clinical study will investigate the relationships between sequential respiratory viral infections, patterns of intestinal and respiratory bacterial colonization, and adaptive cellular immune phenotypes which are associated with increased susceptibility to respiratory infections and long term respiratory morbidity in preterm and full term infants. This is a prospective, cohort study, enrolling at a single center via two sites (URMC and URMC-affiliated Highland Hospital and Rochester General Hospital). Enrollment will be accomplished in approximately 15 - 36 months. The study will enroll 280 subjects, 150 pre-term and 130 full-term.
Interventions
- DEVICE Respiratory Inductive Plethysmography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 267 participants |
| Start Date | 2013-03-27 |
| Est. Completion | 2019-12-31 |
What the finished NCT01789268 record still lists
NCT01789268 is an observational study that tracks outcomes without assigning an intervention. The registered 267 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Respiratory Inductive Plethysmography is the first listed.
NCT01789268 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01789268 about?
NCT01789268 is a clinical study titled "Impact of Respiratory Pathogens in Infants". This clinical study will investigate the relationships between sequential respiratory viral infections, patterns of intestinal and respiratory bacterial colonization, and adaptive cellular immune phenotypes which are associated with increased susceptibility to respiratory infections and long term re...
What is the current status of trial NCT01789268?
This trial is currently completed. The enrollment target is 267 participants. The study started on 2013-03-27. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT01789268?
The interventions under investigation include: Respiratory Inductive Plethysmography (DEVICE).
Who is sponsoring clinical trial NCT01789268?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04997109 · 267 participants · NA
Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy
- NCT05355701 · 267 participants · Phase 1
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
- NCT06203509 · 267 participants · NA
Improving Care Transitions for Medicaid Insured Individuals With Co-occurring Serious Mental Illness
- NCT05000632 · 268 participants · NA
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI